X-132077299-C-A

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_194277.3(FRMD7):​c.*573G>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000698 in 111,680 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 19 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00070 ( 0 hom., 19 hem., cov: 23)
Exomes 𝑓: 0.0 ( 0 hom. 0 hem. )
Failed GnomAD Quality Control

Consequence

FRMD7
NM_194277.3 3_prime_UTR

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.242

Publications

0 publications found
Variant links:
Genes affected
FRMD7 (HGNC:8079): (FERM domain containing 7) Predicted to enable guanyl-nucleotide exchange factor activity. Predicted to be involved in regulation of neuron projection development. Predicted to act upstream of or within several processes, including negative regulation of stress fiber assembly; positive regulation of lamellipodium assembly; and positive regulation of small GTPase mediated signal transduction. Located in cytosol; nucleoplasm; and plasma membrane. Implicated in congenital nystagmus 1. [provided by Alliance of Genome Resources, Apr 2022]
FRMD7 Gene-Disease associations (from GenCC):
  • nystagmus 1, congenital, X-linked
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000698 (78/111680) while in subpopulation AFR AF = 0.00221 (68/30741). AF 95% confidence interval is 0.00179. There are 0 homozygotes in GnomAd4. There are 19 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Hemizygotes in GnomAd4 at 19 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_194277.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FRMD7
NM_194277.3
MANE Select
c.*573G>T
3_prime_UTR
Exon 12 of 12NP_919253.1Q6ZUT3-1
FRMD7
NM_001306193.2
c.*573G>T
3_prime_UTR
Exon 12 of 12NP_001293122.1Q6ZUT3-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FRMD7
ENST00000298542.9
TSL:1 MANE Select
c.*573G>T
3_prime_UTR
Exon 12 of 12ENSP00000298542.3Q6ZUT3-1
FRMD7
ENST00000370879.5
TSL:1
c.*573G>T
3_prime_UTR
Exon 8 of 8ENSP00000359916.1X6R7S7

Frequencies

GnomAD3 genomes
AF:
0.000698
AC:
78
AN:
111680
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00221
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000667
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00134
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1661
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
307
African (AFR)
AF:
0.00
AC:
0
AN:
6
American (AMR)
AF:
0.00
AC:
0
AN:
355
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
11
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37
South Asian (SAS)
AF:
0.00
AC:
0
AN:
96
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
23
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1067
Other (OTH)
AF:
0.00
AC:
0
AN:
66
GnomAD4 genome
AF:
0.000698
AC:
78
AN:
111680
Hom.:
0
Cov.:
23
AF XY:
0.000561
AC XY:
19
AN XY:
33864
show subpopulations
African (AFR)
AF:
0.00221
AC:
68
AN:
30741
American (AMR)
AF:
0.000667
AC:
7
AN:
10496
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2647
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3572
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2681
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6036
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
240
European-Non Finnish (NFE)
AF:
0.0000188
AC:
1
AN:
53085
Other (OTH)
AF:
0.00134
AC:
2
AN:
1497
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000142
Hom.:
0
Bravo
AF:
0.000812

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Nystagmus 1, congenital, X-linked (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
4.3
DANN
Benign
0.77
PhyloP100
0.24
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs963218129; hg19: chrX-131211327; API